Accessibility Menu

Satellos Bioscience

(NASDAQ) MSLE

Current Price$6.51
Market Cap$117.07M
Since IPO (2021)-74%
5 Year-70%
1 Year+17%
1 Month-17%

Satellos Bioscience Financials at a Glance

Market Cap

$117.07M

Revenue (TTM)

$0.00

Net Income (TTM)

-$28.50M

EPS (TTM)

-$1.81

P/E Ratio

-3.10

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$6.51

Volume

46,601.984

Open

$5.73

Previous Close

$5.62

Daily Range

$5.72 - $6.50

52-Week Range

$4.56 - $13.39

Estimated Earnings Date

Aug 12, 2026

MSLE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Satellos Bioscience

Industry

Biotechnology

Employees

18

CEO

Frank Gleeson, MBA

Headquarters

Toronto, ON M5J 2J1, CA

MSLE Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-51.42%

Return on Capital

-95.23%

Return on Assets

-25.56%

Earnings Yield

-32.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$117.07M

Shares Outstanding

20.83M

Volume

46.60K

Avg. Volume

46.32K

Financials (TTM)

Gross Profit

-$5.00K

Operating Income

-$30.02M

EBITDA

-$30.02M

Operating Cash Flow

-$25.68M

Capital Expenditure

-$9.94K

Free Cash Flow

-$25.69M

Cash & ST Invst.

$70.14M

Total Debt

$0.00

Satellos Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$986.00

+1.1%

Gross Margin

0.00%

N/A

Market Cap

$117.07M

N/A

Market Cap/Employee

$6.50M

N/A

Employees

18

N/A

Net Income

-$9.77M

-59.1%

EBITDA

-$10.04M

-55.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$70.14M

+70.3%

Total Debt

$0.00

N/A

Accounts Receivable

$728.39K

+115.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-25.56%

N/A

Return on Invested Capital

-20.67%

N/A

Free Cash Flow

-$9.46M

-28.4%

Operating Cash Flow

-$9.45M

-28.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,371.64+0.00%
^DJIDJI
$51,962.12+0.01%
^IXICNASDAQ
$25,547.61-0.00%
BTCBitcoin
$59,524.00-0.04%

Trending Stocks

Symbol / CompanyPricePrice Chg
WENWendy's
$7.62-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$75.47+0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.41+0.03%
TECHBio-Techne
$70.50+0.20%

Questions About MSLE

What is the current price of Satellos Bioscience?

Satellos Bioscience is trading at $6.34 per share.

What is the 52-week range for Satellos Bioscience?

Over the past 52 weeks, Satellos Bioscience has traded between $4.56 and $13.39.

How much debt does Satellos Bioscience have?

As of the most recent reporting period, Satellos Bioscience reported total debt of $0.00.

How much cash does Satellos Bioscience have on hand?

Satellos Bioscience reported $18.70M in cash and cash equivalents in its most recent financial results.

What is Satellos Bioscience’s dividend yield?

Satellos Bioscience does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.